The 2024 AHA/ACC guideline defines elevated perioperative risk as a >1% chance of major adverse cardiovascular events and discourages extensive preoperative testing for low-risk procedures.
The 2024 AHA/ACC guideline provides updated recommendations for perioperative cardiovascular evaluation, emphasizing targeted testing and ongoing guideline-directed medical therapy.
The 2024 guideline addresses perioperative cardiovascular risk in adults aged over 18 years planning noncardiac procedures, focusing on those with risk factors or conditions that increase perioperative risk. It emphasizes guideline-directed medical therapy, which includes clinical evaluation, targeted testing, and appropriate medical or interventional treatments for both short-term and long-term benefits. The guideline stresses the need for ongoing care and lifestyle modifications beyond the surgical period to reduce risk and improve long-term outcomes. Elevated risk is defined as a greater than 1% chance of major adverse cardiovascular events, but extensive preoperative testing is discouraged for low-risk procedures.
BobbieJean Sweitzer (2026) conducted a review in Perioperative cardiovascular risk in noncardiac surgeries. 2024 AHA/ACC Joint Committee Clinical Practice Guidelines was evaluated. The 2024 AHA/ACC guideline defines elevated perioperative risk as a >1% chance of major adverse cardiovascular events and discourages extensive preoperative testing for low-risk procedures.